The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics.
The Boston-based startup will use the funding to flesh out its diagnostic platform to detect antibiotic-resistant bacterial infections within a clinically relevant timeframe.
In seven years, the public variant classification database has steadily become a resource that labs are submitting to and that genetics experts are consulting.
By leveraging HealthShare's Informatic Exchange solution, Rhodes Group will create a longitudinal, standardized data repository across TriCore's laboratories.
